SE1 0.00% 0.2¢ sensera limited

US $3m+ of COVID Detection Sensor Orders, page-153

  1. 132 Posts.
    lightbulb Created with Sketch. 76
    The NanoDx™ System for SARS-CoV-2 addresses existing diagnostic challenges by providing a rapid assessment from a nasal, throat, saliva, or finger stick of blood sample in a 2 minute test – all in a simple, low-cost system that includes a portable handheld, analyzer, disposable cartridges and secure software for seamless systems integration. The NanoDx™ System for SARS-CoV-2 uses a patented nanosensor technology platform to detect the presence of infections in the blood.

    just checking for those detail oriented if this has or hasn't been updated recently to include assessment across all modalities
 
watchlist Created with Sketch. Add SE1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.